Answers are grounded in this paper and cite their sources.
This study assesses mean emissions and costs and estimated total yearly emissions and costs for US-branded inhalers prescribed to Medicare Part D and Medicaid beneficiaries.
No takes yet. Share an insight, caveat, or question.
Tirumalasetty et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: